NoemaLife, Europe’s leading provider of clinical and hospital software solutions, will exhibit the company’s HALIA middleware for clinical chemistry, microbiology and molecular biology labs at this year’s AACC (American Association of Clinical Chemists) Annual Meeting (15-19 July 2012, Los Angeles, CA).
HALIA middleware interface provides a complete web-based lab computerisation system that allows central management and connection of all analysers through a single interface on any workstation. Using a user-configurable, rule-based engine, HALIA delivers all-round control over laboratory workflow and sample processing for significant improvements in laboratory efficiency, compliance and quality control.
Auto-verification, sample routing and real-time clinical data capture and management, enable improved quality control. By supporting open automation systems, and addressing issues such as regulatory compliance, workforce reductions and enhanced quality control, HALIA meets the complex automation and data management challenges currently facing laboratory managers.
Growing levels of Point of Care Testing are reflected in HALIA’s POCT Data Manager function. This gives lab managers a real-time overview of all the data relating to multiple blood gas analysers or other devices, including instrument maintenance schedules and QC alerts.
Importantly, HALIA also provides detailed real-time data on total turnaround time (TAT) – a key performance indicator in laboratories striving to increase throughput. Addressing the situation where works stops if a LIS/LIMS system goes down, HALIA’s LIS/LIMS backup module allows manual input of sample information so that analysis can continue. Manual samples are then matched to LIS/LIMS data once the connection is restored.
Andrea Chiapponi, Managing Director of NoemaLife S.p.A., commented, ‘In addition to laboratories looking for open middleware which is vendor independent, HALIA will be of interest to IVD device vendors wanting to create turnkey solutions which include maximum LIS/LIMS connectivity. HALIA’s vendor-independence also enables merging of laboratories and even hospitals with different LIS/LIMS solutions into a seamless wide area network. For example, HALIA can manage re-tests on different analysers deployed in separate labs and co-ordinate specimen storage information relating to multiple locations.’
HALIA takes middleware to new levels by providing complete flexibility with simplified integration for all healthcare situations.
Engineered protein silences harmful T cells in autoimmune disease